Anti-Human FSH – HRP
Anti-Human FSH – HRP
Product No.: H101
- -
- -
Clone 181 Target FSH Formats AvailableView All Product Type Monoclonal Antibody Alternate Names Follicle Stimulating Hormone Beta Isotype IgG Applications ELISA Det |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Immunogen Purified Recombinant Human Follicle Stimulating Hormone Beta (>98%) Product Concentration 0.5 mg/ml Formulation This horseradish peroxidase conjugate is supplied in a specially formulated stabilization diluent.(Leinco Prod. No.: S509) Storage and Handling Stable for at least one year when stored at 2°C - 8°C. Do not freeze. Cross Reactivity Paired with Leinco Prod. No. F103, Clone No. 176: FSH 100%, BhCG <1%, LH <4%, ihCG*, TSH <1% *3,000 mlU/ml hCG causes 4.5% decrease in observed FSH. At higher concentrations of hCG, observed FSH reduced to zero.
Paired with Leinco Prod. No. C102, Clone No. 151: FSH 100%, BhCG <1%, ihCG **, FSH <1%, TSH <1%.** At high concentrations of hCG, observed FSH reduced to zero. Country of Origin USA Shipping Next Day 2-8°C RRIDAB_2830303 Applications and Recommended Usage? Quality Tested by Leinco ELISA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Mouse Anti-Human Follicle Stimulating Hormone β (Clone 181) recognizes Human Follicle Stimulating Hormone β. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Background Follicle-stimulating hormone (FSH) is a heterodimeric glycoprotein and is composed of alpha and beta subunits. Alpha subunit is common to FSH and LH, while a unique beta subunit determines the biological specificity of each hormone. The synthesis of beta subunit is the primary rate-limiting step in the synthesis of each hormone.1 Human mutations in the FSH beta gene have been shown to produce complete deficiency states in which pubertal development and reproductive capacity are inhibited.2 PubMed Research Area Hormones . IVD Raw Material References & Citations1. Ryu KZ et al. (2000) J Korean Soc Endocrinol. 15: 179
2. Sluss Patrick et al. (2002) J clin endocrin and metabolism 87: 3702 Technical ProtocolsELISA Det Certificate of Analysis |
Formats Available
- -
- -
Prod No. | Description |
---|---|
F102 | |
H101 |
